BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1970155)

  • 1. Similar early gene responses to ligand-activated EGFR and neu tyrosine kinases in NIH3T3 cells.
    Koskinen P; Lehväslaiho H; MacDonald-Bravo H; Alitalo K; Bravo R
    Oncogene; 1990 Apr; 5(4):615-8. PubMed ID: 1970155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
    J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of an EGFR/neu chimeric receptor: early intracellular signals and cell proliferation responses.
    Pandiella A; Lehvaslaiho H; Magni M; Alitalo K; Meldolesi J
    Oncogene; 1989 Nov; 4(11):1299-305. PubMed ID: 2573029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of the early genomic growth factor response in neu oncogene-transformed cells.
    Sistonen L; Koskinen PJ; Lehväslaiho H; Lehtola L; Bravo R; Alitalo K
    Oncogene; 1990 Jun; 5(6):815-21. PubMed ID: 1972791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y; Wada T; Myers JN; Brown VI; Dobashi K; Cohen J; Hamuro J; Weiner DB; Greene MI
    Princess Takamatsu Symp; 1988; 19():45-57. PubMed ID: 2908355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase.
    Lehväslaiho H; Sistonen L; diRenzo F; Partanen J; Comoglio P; Hölttä E; Alitalo K
    J Cell Biochem; 1990 Mar; 42(3):123-33. PubMed ID: 1969420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic changes of cell phenotype caused by elevated expression of an exogenous NEU proto-oncogene.
    Tarakhovsky AM; Resnikov M; Zaichuk T; Tugusheva MV; Butenko ZA; Prassolov VS
    Oncogene; 1990 Mar; 5(3):405-10. PubMed ID: 1969137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ; Ince C; Rosenblum MG; Gallick GE
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation.
    Qian X; Dougall WC; Hellman ME; Greene MI
    Oncogene; 1994 May; 9(5):1507-14. PubMed ID: 7908733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neu and its ligands: from an oncogene to neural factors.
    Peles E; Yarden Y
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.
    Lonardo F; Di Marco E; King CR; Pierce JH; Segatto O; Aaronson SA; Di Fiore PP
    New Biol; 1990 Nov; 2(11):992-1003. PubMed ID: 1983208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers.
    Freeman MR; Washecka R; Chung LW
    Cancer Res; 1989 Nov; 49(22):6221-5. PubMed ID: 2572319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of epidermal growth factor on the expression of erb B2/neu oncogene in mouse embryo fibroblast cells].
    Zheng YS; Tong TJ
    Shi Yan Sheng Wu Xue Bao; 1992 Dec; 25(4):413-6. PubMed ID: 1363854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins.
    Wada T; Myers JN; Kokai Y; Brown VI; Hamuro J; LeVea CM; Greene MI
    Oncogene; 1990 Apr; 5(4):489-95. PubMed ID: 1970151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor.
    Muthuswamy SK; Muller WJ
    Oncogene; 1995 Jul; 11(2):271-9. PubMed ID: 7542762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy.
    Dougall WC; Qian X; Greene MI
    J Cell Biochem; 1993 Sep; 53(1):61-73. PubMed ID: 7901229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
    Weidner U; Peter S; Strohmeyer T; Hussnätter R; Ackermann R; Sies H
    Cancer Res; 1990 Aug; 50(15):4504-9. PubMed ID: 1973362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the neu proto-oncogene by Schwann cells during peripheral nerve development and Wallerian degeneration.
    Cohen JA; Yachnis AT; Arai M; Davis JG; Scherer SS
    J Neurosci Res; 1992 Apr; 31(4):622-34. PubMed ID: 1374476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.